Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential benefits. Preliminary findings suggest that this higher dosage may amplify the drug's ability to regulate blood glucose, potentially offering greater outcomes for individuals with type 2 diabetes. Further investigation is underway to fully understand